PALLAS
Kenji Uematsu is a seasoned professional with extensive experience in corporate development, strategic planning, and financial management across various industries, including nuclear energy, manufacturing, and telecommunications. Currently serving as the Corporate Development and Financing Manager at NRG PALLAS since October 2020, Kenji is focused on ensuring the production of medical isotopes and research initiatives. Previous roles include Vice President of Strategic Planning and Business Development at Diamond Tools Group and Director of Strategic Business Planning at C&K. Kenji's career also features positions in mergers and acquisitions at KPN and Telfort, as well as financial analysis roles at companies like Sony Computer Entertainment and Lehman Brothers. Kenji holds an MBA from The Tuck School of Business at Dartmouth and a BA in Engineering Sciences from Dartmouth College.
This person is not in any offices
PALLAS
1 followers
Foundation Preparation Pallas-reactor (PALLAS) is responsible for obtaining a licensable design, obtaining private investors, and constructing and operating the PALLAS-reactor. The new reactor will be one of the most leading reactors in the world: PALLAS will help tens of thousands patients every day by providing medical isotopes. These are the radioactive particles in nuclear medicine that are crucial elements in order to diagnose or treat illnesses such as heart and vascular disease and cancer. PALLAS will also be an important player in (medical) nuclear technological research.